Desq Long
Sign in

Company

Oruka Therapeutics, Inc.

ORKA · CIK 0000907654

SEC FORM 4
$78,000.00

Oruka Therapeutics, Inc. (ORKA)

Acquisition (code M) of 10,000 shares at $7.8 per share.

Reporting Person Quinlan Paul T · Officer Title General Counsel · Transaction Code M

Traded Sep 21, 2026 · Disclosed Sep 21, 2026

Source: SEC Form 4 · 0000907654-26-000100 · filed 2026-09-21 · View filing →

SEC FORM 4
$267,869.81

Oruka Therapeutics, Inc. (ORKA)

Sale of 2,900 shares at $92.3689 per share.

Reporting Person Quinlan Paul T · Officer Title General Counsel · Transaction Code S

Traded Sep 21, 2026 · Disclosed Sep 21, 2026

Source: SEC Form 4 · 0000907654-26-000100 · filed 2026-09-21 · View filing →

SEC FORM 4
$357,591.89

Oruka Therapeutics, Inc. (ORKA)

Sale of 3,832 shares at $93.3173 per share.

Reporting Person Quinlan Paul T · Officer Title General Counsel · Transaction Code S

Traded Sep 21, 2026 · Disclosed Sep 21, 2026

Source: SEC Form 4 · 0000907654-26-000100 · filed 2026-09-21 · View filing →

SEC FORM 4
$56,760.00

Oruka Therapeutics, Inc. (ORKA)

Sale of 601 shares at $94.4426 per share.

Reporting Person Quinlan Paul T · Officer Title General Counsel · Transaction Code S

Traded Sep 21, 2026 · Disclosed Sep 21, 2026

Source: SEC Form 4 · 0000907654-26-000100 · filed 2026-09-21 · View filing →

SEC FORM 4
$254,195.77

Oruka Therapeutics, Inc. (ORKA)

Sale of 2,667 shares at $95.3115 per share.

Reporting Person Quinlan Paul T · Officer Title General Counsel · Transaction Code S

Traded Sep 21, 2026 · Disclosed Sep 21, 2026

Source: SEC Form 4 · 0000907654-26-000100 · filed 2026-09-21 · View filing →

SEC FORM 4
$51,034.75

Oruka Therapeutics, Inc. (ORKA)

Sale of 533 shares at $95.75 per share.

Reporting Person Agarwal Arjun · Officer Title Senior Vice President, Finance · Transaction Code S

Traded Sep 21, 2026 · Disclosed Sep 21, 2026

Source: SEC Form 4 · 0000907654-26-000102 · filed 2026-09-21 · View filing →

SEC FORM 4
$86,713.26

Oruka Therapeutics, Inc. (ORKA)

Sale of 906 shares at $95.71 per share.

Reporting Person Sandler Laura Lee · Officer Title Chief Operating Officer · Transaction Code S

Traded Sep 15, 2026 · Disclosed Sep 15, 2026

Source: SEC Form 4 · 0000907654-26-000094 · filed 2026-09-15 · View filing →

SEC FORM 4
$99,442.69

Oruka Therapeutics, Inc. (ORKA)

Sale of 1,039 shares at $95.71 per share.

Reporting Person Quinlan Paul T · Officer Title General Counsel · Transaction Code S

Traded Sep 15, 2026 · Disclosed Sep 15, 2026

Source: SEC Form 4 · 0000907654-26-000095 · filed 2026-09-15 · View filing →

SEC FORM 4
$234,680.92

Oruka Therapeutics, Inc. (ORKA)

Sale of 2,452 shares at $95.71 per share.

Reporting Person Klein Lawrence Otto · Officer Title Chief Executive Officer · Transaction Code S

Traded Sep 15, 2026 · Disclosed Sep 15, 2026

Source: SEC Form 4 · 0000907654-26-000096 · filed 2026-09-15 · View filing →

SEC FORM 4
$53,597.60

Oruka Therapeutics, Inc. (ORKA)

Sale of 560 shares at $95.71 per share.

Reporting Person Agarwal Arjun · Officer Title Senior Vice President, Finance · Transaction Code S

Traded Sep 15, 2026 · Disclosed Sep 15, 2026

Source: SEC Form 4 · 0000907654-26-000097 · filed 2026-09-15 · View filing →

SEC FORM 4
$23,940.00

Oruka Therapeutics, Inc. (ORKA)

Acquisition (code M) of 3,500 shares at $6.84 per share.

Reporting Person Goncalves Joana · Officer Title Chief Medical Officer · Transaction Code M

Traded Sep 15, 2026 · Disclosed Sep 15, 2026

Source: SEC Form 4 · 0000907654-26-000098 · filed 2026-09-15 · View filing →

SEC FORM 4
$27,300.00

Oruka Therapeutics, Inc. (ORKA)

Acquisition (code M) of 3,500 shares at $7.80 per share.

Reporting Person Goncalves Joana · Officer Title Chief Medical Officer · Transaction Code M

Traded Sep 15, 2026 · Disclosed Sep 15, 2026

Source: SEC Form 4 · 0000907654-26-000098 · filed 2026-09-15 · View filing →

SEC FORM 4
$217,173.34

Oruka Therapeutics, Inc. (ORKA)

Sale of 2,384 shares at $91.0962 per share.

Reporting Person Goncalves Joana · Officer Title Chief Medical Officer · Transaction Code S

Traded Sep 15, 2026 · Disclosed Sep 15, 2026

Source: SEC Form 4 · 0000907654-26-000098 · filed 2026-09-15 · View filing →

SEC FORM 4
$289,889.77

Oruka Therapeutics, Inc. (ORKA)

Sale of 3,150 shares at $92.0285 per share.

Reporting Person Goncalves Joana · Officer Title Chief Medical Officer · Transaction Code S

Traded Sep 15, 2026 · Disclosed Sep 15, 2026

Source: SEC Form 4 · 0000907654-26-000098 · filed 2026-09-15 · View filing →

SEC FORM 4
$127,022.70

Oruka Therapeutics, Inc. (ORKA)

Sale of 1,366 shares at $92.9888 per share.

Reporting Person Goncalves Joana · Officer Title Chief Medical Officer · Transaction Code S

Traded Sep 15, 2026 · Disclosed Sep 15, 2026

Source: SEC Form 4 · 0000907654-26-000098 · filed 2026-09-15 · View filing →

SEC FORM 4
$9,421.72

Oruka Therapeutics, Inc. (ORKA)

Sale of 100 shares at $94.2172 per share.

Reporting Person Goncalves Joana · Officer Title Chief Medical Officer · Transaction Code S

Traded Sep 15, 2026 · Disclosed Sep 15, 2026

Source: SEC Form 4 · 0000907654-26-000098 · filed 2026-09-15 · View filing →

SEC FORM 4
$90,637.37

Oruka Therapeutics, Inc. (ORKA)

Sale of 947 shares at $95.71 per share.

Reporting Person Goncalves Joana · Officer Title Chief Medical Officer · Transaction Code S

Traded Sep 15, 2026 · Disclosed Sep 15, 2026

Source: SEC Form 4 · 0000907654-26-000098 · filed 2026-09-15 · View filing →

SEC FORM 4
$100,000.00

Oruka Therapeutics, Inc. (ORKA)

Acquisition (code M) of 8,000 shares at $12.5 per share.

Reporting Person Agarwal Arjun · Officer Title Senior Vice President, Finance · Transaction Code M

Traded Sep 11, 2026 · Disclosed Sep 15, 2026

Source: SEC Form 4 · 0000907654-26-000097 · filed 2026-09-15 · View filing →

SEC FORM 4
$50,175.01

Oruka Therapeutics, Inc. (ORKA)

Acquisition (code M) of 1,459 shares at $34.39 per share.

Reporting Person Agarwal Arjun · Officer Title Senior Vice President, Finance · Transaction Code M

Traded Sep 11, 2026 · Disclosed Sep 15, 2026

Source: SEC Form 4 · 0000907654-26-000097 · filed 2026-09-15 · View filing →

SEC FORM 4
$273,321.90

Oruka Therapeutics, Inc. (ORKA)

Sale of 3,000 shares at $91.1073 per share.

Reporting Person Agarwal Arjun · Officer Title Senior Vice President, Finance · Transaction Code S

Traded Sep 11, 2026 · Disclosed Sep 15, 2026

Source: SEC Form 4 · 0000907654-26-000097 · filed 2026-09-15 · View filing →

SEC FORM 4
$374,367.09

Oruka Therapeutics, Inc. (ORKA)

Sale of 4,051 shares at $92.4135 per share.

Reporting Person Agarwal Arjun · Officer Title Senior Vice President, Finance · Transaction Code S

Traded Sep 11, 2026 · Disclosed Sep 15, 2026

Source: SEC Form 4 · 0000907654-26-000097 · filed 2026-09-15 · View filing →

SEC FORM 4
$205,920.51

Oruka Therapeutics, Inc. (ORKA)

Sale of 2,208 shares at $93.2611 per share.

Reporting Person Agarwal Arjun · Officer Title Senior Vice President, Finance · Transaction Code S

Traded Sep 11, 2026 · Disclosed Sep 15, 2026

Source: SEC Form 4 · 0000907654-26-000097 · filed 2026-09-15 · View filing →

SEC FORM 4
$18,803.00

Oruka Therapeutics, Inc. (ORKA)

Sale of 200 shares at $94.015 per share.

Reporting Person Agarwal Arjun · Officer Title Senior Vice President, Finance · Transaction Code S

Traded Sep 11, 2026 · Disclosed Sep 15, 2026

Source: SEC Form 4 · 0000907654-26-000097 · filed 2026-09-15 · View filing →

SEC FORM 4
$585,000.00

Oruka Therapeutics, Inc. (ORKA)

Acquisition (code M) of 75,000 shares at $7.8 per share.

Reporting Person Klein Lawrence Otto · Officer Title Chief Executive Officer · Transaction Code M

Traded Sep 1, 2026 · Disclosed Sep 1, 2026

Source: SEC Form 4 · 0000907654-26-000087 · filed 2026-09-01 · View filing →

SEC FORM 4
$599,556.03

Oruka Therapeutics, Inc. (ORKA)

Sale of 6,604 shares at $90.7868 per share.

Reporting Person Klein Lawrence Otto · Officer Title Chief Executive Officer · Transaction Code S

Traded Sep 1, 2026 · Disclosed Sep 1, 2026

Source: SEC Form 4 · 0000907654-26-000087 · filed 2026-09-01 · View filing →

SEC FORM 4
$5,844,237.09

Oruka Therapeutics, Inc. (ORKA)

Sale of 63,596 shares at $91.8963 per share.

Reporting Person Klein Lawrence Otto · Officer Title Chief Executive Officer · Transaction Code S

Traded Sep 1, 2026 · Disclosed Sep 1, 2026

Source: SEC Form 4 · 0000907654-26-000087 · filed 2026-09-01 · View filing →

SEC FORM 4
$443,691.36

Oruka Therapeutics, Inc. (ORKA)

Sale of 4,800 shares at $92.4357 per share.

Reporting Person Klein Lawrence Otto · Officer Title Chief Executive Officer · Transaction Code S

Traded Sep 1, 2026 · Disclosed Sep 1, 2026

Source: SEC Form 4 · 0000907654-26-000087 · filed 2026-09-01 · View filing →

SEC FORM 4
$39,000.00

Oruka Therapeutics, Inc. (ORKA)

Acquisition (code M) of 5,000 shares at $7.8 per share.

Reporting Person Sandler Laura Lee · Officer Title Chief Operating Officer · Transaction Code M

Traded Sep 1, 2026 · Disclosed Sep 1, 2026

Source: SEC Form 4 · 0000907654-26-000088 · filed 2026-09-01 · View filing →

SEC FORM 4
$91,047.60

Oruka Therapeutics, Inc. (ORKA)

Sale of 1,000 shares at $91.0476 per share.

Reporting Person Sandler Laura Lee · Officer Title Chief Operating Officer · Transaction Code S

Traded Sep 1, 2026 · Disclosed Sep 1, 2026

Source: SEC Form 4 · 0000907654-26-000088 · filed 2026-09-01 · View filing →

SEC FORM 4
$368,053.60

Oruka Therapeutics, Inc. (ORKA)

Sale of 4,000 shares at $92.0134 per share.

Reporting Person Sandler Laura Lee · Officer Title Chief Operating Officer · Transaction Code S

Traded Sep 1, 2026 · Disclosed Sep 1, 2026

Source: SEC Form 4 · 0000907654-26-000088 · filed 2026-09-01 · View filing →

SEC FORM 4
$0.00

Oruka Therapeutics, Inc. (ORKA)

Acquisition (code A) of 100,000 shares at $0 per share.

Reporting Person Edwards Larry Todd · Officer Title Chief Commercial Officer · Transaction Code A

Traded Aug 24, 2026 · Disclosed Aug 25, 2026

Source: SEC Form 4 · 0000907654-26-000084 · filed 2026-08-25 · View filing →

SEC FORM 4
$23,940.00

Oruka Therapeutics, Inc. (ORKA)

Acquisition (code M) of 3,500 shares at $6.84 per share.

Reporting Person Goncalves Joana · Officer Title Chief Medical Officer · Transaction Code M

Traded Aug 17, 2026 · Disclosed Aug 17, 2026

Source: SEC Form 4 · 0000907654-26-000079 · filed 2026-08-17 · View filing →

SEC FORM 4
$27,300.00

Oruka Therapeutics, Inc. (ORKA)

Acquisition (code M) of 3,500 shares at $7.80 per share.

Reporting Person Goncalves Joana · Officer Title Chief Medical Officer · Transaction Code M

Traded Aug 17, 2026 · Disclosed Aug 17, 2026

Source: SEC Form 4 · 0000907654-26-000079 · filed 2026-08-17 · View filing →

SEC FORM 4
$98,686.98

Oruka Therapeutics, Inc. (ORKA)

Sale of 900 shares at $109.6522 per share.

Reporting Person Goncalves Joana · Officer Title Chief Medical Officer · Transaction Code S

Traded Aug 17, 2026 · Disclosed Aug 17, 2026

Source: SEC Form 4 · 0000907654-26-000079 · filed 2026-08-17 · View filing →

SEC FORM 4
$33,155.01

Oruka Therapeutics, Inc. (ORKA)

Sale of 300 shares at $110.5167 per share.

Reporting Person Goncalves Joana · Officer Title Chief Medical Officer · Transaction Code S

Traded Aug 17, 2026 · Disclosed Aug 17, 2026

Source: SEC Form 4 · 0000907654-26-000079 · filed 2026-08-17 · View filing →

SEC FORM 4
$371,885.82

Oruka Therapeutics, Inc. (ORKA)

Sale of 3,320 shares at $112.0138 per share.

Reporting Person Goncalves Joana · Officer Title Chief Medical Officer · Transaction Code S

Traded Aug 17, 2026 · Disclosed Aug 17, 2026

Source: SEC Form 4 · 0000907654-26-000079 · filed 2026-08-17 · View filing →

SEC FORM 4
$279,154.26

Oruka Therapeutics, Inc. (ORKA)

Sale of 2,480 shares at $112.5622 per share.

Reporting Person Goncalves Joana · Officer Title Chief Medical Officer · Transaction Code S

Traded Aug 17, 2026 · Disclosed Aug 17, 2026

Source: SEC Form 4 · 0000907654-26-000079 · filed 2026-08-17 · View filing →

SEC FORM 4
$78,000.00

Oruka Therapeutics, Inc. (ORKA)

Acquisition (code M) of 10,000 shares at $7.8 per share.

Reporting Person Quinlan Paul T · Officer Title General Counsel · Transaction Code M

Traded Aug 14, 2026 · Disclosed Aug 14, 2026

Source: SEC Form 4 · 0000907654-26-000077 · filed 2026-08-14 · View filing →

SEC FORM 4
$525,000.00

Oruka Therapeutics, Inc. (ORKA)

Acquisition (code M) of 42,000 shares at $12.5 per share.

Reporting Person Quinlan Paul T · Officer Title General Counsel · Transaction Code M

Traded Aug 14, 2026 · Disclosed Aug 14, 2026

Source: SEC Form 4 · 0000907654-26-000077 · filed 2026-08-14 · View filing →

SEC FORM 4
$384,962.95

Oruka Therapeutics, Inc. (ORKA)

Sale of 3,630 shares at $106.0504 per share.

Reporting Person Quinlan Paul T · Officer Title General Counsel · Transaction Code S

Traded Aug 14, 2026 · Disclosed Aug 14, 2026

Source: SEC Form 4 · 0000907654-26-000077 · filed 2026-08-14 · View filing →

SEC FORM 4
$1,117,900.85

Oruka Therapeutics, Inc. (ORKA)

Sale of 10,434 shares at $107.1402 per share.

Reporting Person Quinlan Paul T · Officer Title General Counsel · Transaction Code S

Traded Aug 14, 2026 · Disclosed Aug 14, 2026

Source: SEC Form 4 · 0000907654-26-000077 · filed 2026-08-14 · View filing →

SEC FORM 4
$1,586,778.56

Oruka Therapeutics, Inc. (ORKA)

Sale of 14,696 shares at $107.9735 per share.

Reporting Person Quinlan Paul T · Officer Title General Counsel · Transaction Code S

Traded Aug 14, 2026 · Disclosed Aug 14, 2026

Source: SEC Form 4 · 0000907654-26-000077 · filed 2026-08-14 · View filing →

SEC FORM 4
$1,112,953.62

Oruka Therapeutics, Inc. (ORKA)

Sale of 10,200 shares at $109.1131 per share.

Reporting Person Quinlan Paul T · Officer Title General Counsel · Transaction Code S

Traded Aug 14, 2026 · Disclosed Aug 14, 2026

Source: SEC Form 4 · 0000907654-26-000077 · filed 2026-08-14 · View filing →

SEC FORM 4
$1,011,265.85

Oruka Therapeutics, Inc. (ORKA)

Sale of 9,193 shares at $110.0039 per share.

Reporting Person Quinlan Paul T · Officer Title General Counsel · Transaction Code S

Traded Aug 14, 2026 · Disclosed Aug 14, 2026

Source: SEC Form 4 · 0000907654-26-000077 · filed 2026-08-14 · View filing →

SEC FORM 4
$427,547.12

Oruka Therapeutics, Inc. (ORKA)

Sale of 3,847 shares at $111.1378 per share.

Reporting Person Quinlan Paul T · Officer Title General Counsel · Transaction Code S

Traded Aug 14, 2026 · Disclosed Aug 14, 2026

Source: SEC Form 4 · 0000907654-26-000077 · filed 2026-08-14 · View filing →

SEC FORM 4
$106,775.00

Oruka Therapeutics, Inc. (ORKA)

Acquisition (code M) of 8,542 shares at $12.5 per share.

Reporting Person Agarwal Arjun · Officer Title Senior Vice President, Finance · Transaction Code M

Traded Aug 13, 2026 · Disclosed Aug 14, 2026

Source: SEC Form 4 · 0000907654-26-000075 · filed 2026-08-14 · View filing →

SEC FORM 4
$50,140.62

Oruka Therapeutics, Inc. (ORKA)

Acquisition (code M) of 1,458 shares at $34.39 per share.

Reporting Person Agarwal Arjun · Officer Title Senior Vice President, Finance · Transaction Code M

Traded Aug 13, 2026 · Disclosed Aug 14, 2026

Source: SEC Form 4 · 0000907654-26-000075 · filed 2026-08-14 · View filing →

SEC FORM 4
$219,814.14

Oruka Therapeutics, Inc. (ORKA)

Sale of 2,100 shares at $104.6734 per share.

Reporting Person Agarwal Arjun · Officer Title Senior Vice President, Finance · Transaction Code S

Traded Aug 13, 2026 · Disclosed Aug 14, 2026

Source: SEC Form 4 · 0000907654-26-000075 · filed 2026-08-14 · View filing →

SEC FORM 4
$225,078.65

Oruka Therapeutics, Inc. (ORKA)

Sale of 2,132 shares at $105.5716 per share.

Reporting Person Agarwal Arjun · Officer Title Senior Vice President, Finance · Transaction Code S

Traded Aug 13, 2026 · Disclosed Aug 14, 2026

Source: SEC Form 4 · 0000907654-26-000075 · filed 2026-08-14 · View filing →

SEC FORM 4
$135,201.13

Oruka Therapeutics, Inc. (ORKA)

Sale of 1,268 shares at $106.6255 per share.

Reporting Person Agarwal Arjun · Officer Title Senior Vice President, Finance · Transaction Code S

Traded Aug 13, 2026 · Disclosed Aug 14, 2026

Source: SEC Form 4 · 0000907654-26-000075 · filed 2026-08-14 · View filing →

SEC FORM 4
$230,722.96

Oruka Therapeutics, Inc. (ORKA)

Sale of 2,142 shares at $107.7138 per share.

Reporting Person Agarwal Arjun · Officer Title Senior Vice President, Finance · Transaction Code S

Traded Aug 13, 2026 · Disclosed Aug 14, 2026

Source: SEC Form 4 · 0000907654-26-000075 · filed 2026-08-14 · View filing →

SEC FORM 4
$255,755.28

Oruka Therapeutics, Inc. (ORKA)

Sale of 2,358 shares at $108.4628 per share.

Reporting Person Agarwal Arjun · Officer Title Senior Vice President, Finance · Transaction Code S

Traded Aug 13, 2026 · Disclosed Aug 14, 2026

Source: SEC Form 4 · 0000907654-26-000075 · filed 2026-08-14 · View filing →